Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/183494
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSierra Urueña, Yanik-
dc.contributor.authorTubau, Fe-
dc.contributor.authorGonzález Díaz, Aida-
dc.contributor.authorCarrera-Salinas, Anna-
dc.contributor.authorMoleres, Javier-
dc.contributor.authorBajanca-Lavado, Paula-
dc.contributor.authorGarmendia, J.-
dc.contributor.authorDomínguez Luzón, Ma. Ángeles (María Ángeles)-
dc.contributor.authorArdanuy Tisaire, María Carmen-
dc.contributor.authorMarti Marti, Sara-
dc.date.accessioned2022-02-24T15:49:11Z-
dc.date.available2022-02-24T15:49:11Z-
dc.date.issued2020-07-01-
dc.identifier.issn1198-743X-
dc.identifier.urihttps://hdl.handle.net/2445/183494-
dc.description.abstractObjectives: To compare the determinants of trimethoprim-sulfamethoxazole resistance with established susceptibility values for fastidious Haemophilus spp., to provide recommendations for optimal trimethoprim-sulfamethoxazole measurement. Methods: We collected 50 strains each of Haemophilus influenzae and Haemophilus parainfluenzae at Bellvitge University Hospital. Trimethoprim-sulfamethoxazole susceptibility was tested by microdilution, E-test and disc diffusion using both Mueller-Hinton fastidious (MH-F) medium and Haemophilus test medium (HTM) following EUCAST and CLSI criteria, respectively. Mutations in folA, folP and additional determinants of resistance were identified in whole-genome-sequenced isolates. Results: Strains presented generally higher rates of trimethoprim-sulfamethoxazole resistance when grown on HTM than on MH-F, independent of the methodology used (average MIC 2.6-fold higher in H. influenzae and 1.2-fold higher in H. parainfluenzae). The main resistance-related determinants were as follows: I95L and F154S/V in folA; 3- and 15-bp insertions and substitutions in folP; acquisition of sul genes; and FolA overproduction potentially linked to mutations in -35 and -10 promoter motifs. Of note, 2 of 19 H. influenzae strains (10.5%) and 9 of 33 H. parainfluenzae strains (27.3%) with mutations and assigned as resistant by microdilution were inaccurately considered susceptible by disc diffusion. This misinterpretation was resolved by raising the clinical resistance breakpoint of the EUCAST guidelines to ≤30 mm. Conclusions: Given the routine use of disc diffusion, a significant number of strains could potentially be miscategorized as susceptible to trimethoprim-sulfamethoxazole despite having resistance-related mutations. A simple modification to the current clinical resistance breakpoint given by the EUCAST guideline for MH-F ensures correct interpretation and correlation with the reference standard method of microdilution.-
dc.format.extent7 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherEuropean Society of Clinical Microbiology and Infectious Diseases-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.cmi.2019.11.022-
dc.relation.ispartofClinical Microbiology and Infection, 2020, vol. 26, num. 7-
dc.relation.urihttps://doi.org/10.1016/j.cmi.2019.11.022-
dc.rights(c) Sierra Urueña, Yanik et al., 2020-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationMalalties bacterianes-
dc.subject.classificationAntibiòtics-
dc.subject.classificationEstabilitat dels medicaments-
dc.subject.classificationBacils-
dc.subject.otherBacterial diseases-
dc.subject.otherAntibiotics-
dc.subject.otherDrug stability-
dc.subject.otherBacillus (Bacteria)-
dc.titleAssessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec709403-
dc.date.updated2022-02-24T15:49:11Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid31811916-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
709403.pdf1.22 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.